Victory Capital Management Inc Moderna, Inc. Transaction History

Victory Capital Management Inc

$95.8 Billion
Q2 2024

A detailed history of Victory Capital Management Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 284,337 shares of MRNA stock, worth $18.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

284,337

Previous 299,510 5.07%

Holding current value

$18.7 Million

Previous $31.9 Million 5.8%

% of portfolio

0.04%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$101.21 - $166.61 $1.54 Million - $2.53 Million	-15,173 Reduced 5.07%	284,337 $33.8 Million
Q1 2024 May 03, 2024	SELL	$85.37 - $115.44 $309,210 - $418,123	-3,622 Reduced 1.19%	299,510 $31.9 Million
Q4 2023 Feb 05, 2024	BUY	$69.51 - $104.43 $1.47 Million - $2.21 Million	21,135 Added 7.49%	303,132 $30.1 Million
Q3 2023 Nov 06, 2023	BUY	$96.41 - $126.61 $3.12 Million - $4.1 Million	32,371 Added 12.97%	281,997 $29.1 Million
Q2 2023 Jul 27, 2023	SELL	$118.5 - $160.53 $4.14 Million - $5.61 Million	-34,960 Reduced 12.28%	249,626 $30.3 Million
Q1 2023 May 02, 2023	SELL	$135.66 - $197.02 $24.9 Million - $36.2 Million	-183,747 Reduced 39.23%	284,586 $43.7 Million
Q4 2022 Feb 10, 2023	BUY	$118.38 - $210.04 $806,049 - $1.43 Million	6,809 Added 1.48%	468,333 $84.1 Million
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $20.2 Million - $35.8 Million	170,238 Added 58.44%	461,524 $82.9 Million
Q3 2022 Nov 02, 2022	BUY	$118.07 - $194.18 $3.17 Million - $5.21 Million	26,838 Added 10.15%	291,286 $34.4 Million
Q2 2022 Aug 01, 2022	SELL	$117.13 - $176.59 $1.32 Million - $1.99 Million	-11,285 Reduced 4.09%	264,448 $37.8 Million
Q1 2022 May 04, 2022	BUY	$126.46 - $235.05 $2.44 Million - $4.54 Million	19,330 Added 7.54%	275,733 $37.1 Million
Q4 2021 Feb 07, 2022	BUY	$225.82 - $368.51 $4.91 Million - $8.01 Million	21,738 Added 9.26%	256,403 $65.1 Million
Q3 2021 Nov 02, 2021	SELL	$221.9 - $484.47 $12.1 Million - $26.3 Million	-54,370 Reduced 18.81%	234,665 $90.3 Million
Q2 2021 Aug 03, 2021	SELL	$129.91 - $234.98 $866,759 - $1.57 Million	-6,672 Reduced 2.26%	289,035 $67.9 Million
Q1 2021 May 04, 2021	SELL	$109.18 - $185.98 $2.25 Million - $3.83 Million	-20,601 Reduced 6.51%	295,707 $38.7 Million
Q4 2020 Feb 01, 2021	BUY	$65.74 - $169.86 $3.05 Million - $7.88 Million	46,409 Added 17.19%	316,308 $33 Million
Q3 2020 Nov 09, 2020	BUY	$54.34 - $94.85 $12.1 Million - $21.1 Million	222,174 Added 465.53%	269,899 $19.1 Million
Q2 2020 Aug 07, 2020	BUY	$29.67 - $80.0 $299,993 - $808,880	10,111 Added 26.88%	47,725 $3.06 Million
Q1 2020 May 04, 2020	SELL	$17.78 - $31.58 $65,625 - $116,561	-3,691 Reduced 8.94%	37,614 $1.13 Million
Q4 2019 Feb 06, 2020	BUY	$13.93 - $21.28 $24,266 - $37,069	1,742 Added 4.4%	41,305 $808,000
Q4 2019 Feb 04, 2020	BUY	$13.93 - $21.28 $121,985 - $186,348	8,757 Added 28.43%	39,563 $811,000
Q3 2019 Nov 12, 2019	BUY	$12.26 - $18.07 $377,681 - $556,664	30,806 New	30,806 $490,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Moderna, Inc. Transaction History